Characterization of a novel immunoglobulin-like domain containing receptor

Biochemical and Biophysical Research Communications

Volumn 323, Issue 3, 2004, Pages 970-978

  Hauge, Helena ^a   Patzke, Sebastian ^a   Delabie, Jan ^a   Aasheim, Hans Christian ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Alternative splicing; Cancer; Diagnostic marker; Gene expression; ILDR1

Indexed keywords

LOW DENSITY LIPOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CELLULAR DISTRIBUTION; CHROMOSOME 3Q; CONTROLLED STUDY; CYTOPLASM; GENE; GENE EXPRESSION; GENE SEQUENCE; GENE TRANSLOCATION; GENETIC ANALYSIS; HEART; HUMAN; HUMAN CELL; IMMUNOGLOBULIN LIKE DOMAIN CONTAINING RECEPTOR 1 GENE; KIDNEY; LIVER; LYMPHOMA; NUCLEOTIDE SEQUENCE; PANCREAS; PRIORITY JOURNAL; PROSTATE; TESTIS;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; HUMANS; LYMPHOMA; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; RECEPTORS, CELL SURFACE; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID; SUBCELLULAR FRACTIONS; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 4544330955     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.08.188     Document Type: Article

References (38)

1. N.L. Harris, E.S. Jaffe, H. Stein, P.M. Banks, J.K. Chan, M.L. Cleary, G. Delsol, C. Wolf-Peeters, B. Falini, and K.C. Gatter A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group Blood 84 1994 1361 1392
2. R. Risdall, R.T. Hoppe, and R. Warnke Non-Hodgkin's lymphoma: a study of the evolution of the disease based upon 92 autopsied cases Cancer 44 1979 529 542
3. B. Acker, R.T. Hoppe, T.V. Colby, R.S. Cox, H.S. Kaplan, and S.A. Rosenberg Histologic conversion in the non-Hodgkin's lymphomas J. Clin. Oncol. 1 1983 11 16
4. A.J. Garvin, R.M. Simon, C.K. Osborne, J. Merrill, R.C. Young, and C.W. Berard An autopsy study of histologic progression in non-Hodgkin's lymphoma. 192 cases from the National Cancer Institute Cancer 52 1983 393 398
5. S.J. Horning, and S.A. Rosenberg The natural history of initially untreated low-grade non-Hodgkin's lymphomas N. Engl. J. Med. 311 1984 1471 1475
6. D.T. Ross, U. Scherf, M.B. Eisen, C.M. Perou, C. Rees, P. Spellman, V. Iyer, S.S. Jeffrey, R.M. Van de, M. Waltham, A. Pergamenschikov, J.C. Lee, D. Lashkari, D. Shalon, T.G. Myers, J.N. Weinstein, D. Botstein, and P.O. Brown Systematic variation in gene expression patterns in human cancer cell lines Nat. Genet. 24 2000 227 235
7. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, T. Tran, X. Yu, J.I. Powell, L. Yang, G.E. Marti, T. Moore, J. Hudson Jr., L. Lu, D.B. Lewis, R. Tibshirani, G. Sherlock, W.C. Chan, T.C. Greiner, D.D. Weisenburger, J.O. Armitage, R. Warnke, R. Levy, W. Wilson, M.R. Grever, J.C. Byrd, D. Botstein, P.O. Brown, and L.M. Staudt Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511
8. A.A. Mironov, J.W. Fickett, and M.S. Gelfand Frequent alternative splicing of human genes Genome Res. 9 1999 1288 1293
9. D. Brett, J. Hanke, G. Lehmann, S. Haase, S. Delbruck, S. Krueger, J. Reich, and P. Bork EST comparison indicates 38% of human mRNAs contain possible alternative splice forms FEBS Lett. 474 2000 83 86
10. Z. Kan, E.C. Rouchka, W.R. Gish, and D.J. States Gene structure prediction and alternative splicing analysis using genomically aligned ESTs Genome Res. 11 2001 889 900
11. C.J. Wikstrand, L.P. Hale, S.K. Batra, M.L. Hill, P.A. Humphrey, S.N. Kurpad, R.E. McLendon, D. Moscatello, C.N. Pegram, and C.J. Reist Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas Cancer Res. 55 1995 3140 3148
12. A. Parareda, J.C. Villaescusa, d.T. Sanchez, and S. Gallego New splicing variants for human tyrosine hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma Neurosci. Lett. 336 2003 29 32
13. M. Koslowski, O. Tureci, C. Bell, P. Krause, H.A. Lehr, J. Brunner, G. Seitz, F.O. Nestle, C. Huber, and U. Sahin Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer Cancer Res. 62 2002 6750 6755
14. C.M. Feltes, A. Kudo, O. Blaschuk, and S.W. Byers An alternatively spliced cadherin-11 enhances human breast cancer cell invasion Cancer Res. 62 2002 6688 6697
15. P. Castellani, L. Borsi, B. Carnemolla, A. Biro, A. Dorcaratto, G.L. Viale, D. Neri, and L. Zardi Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin Am. J. Pathol. 161 2002 1695 1700
16. Q. Xu, and C. Lee Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences Nucleic Acids Res. 31 2003 5635 5643
17. Z. Wang, H.S. Lo, H. Yang, S. Gere, Y. Hu, K.H. Buetow, and M.P. Lee Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer Cancer Res. 63 2003 655 657
18. L. Hui, X. Zhang, X. Wu, Z. Lin, Q. Wang, Y. Li, and G. Hu Identification of alternatively spliced mRNA variants related to cancers by genome-wide ESTs alignment Oncogene 23 2004 3013 3023
19. K. Ge, J. DuHadaway, W. Du, M. Herlyn, U. Rodeck, and G.C. Prendergast Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma Proc. Natl. Acad. Sci. USA 96 1999 9689 9694
20. M.S. Cragg, H.T. Chan, M.D. Fox, A. Tutt, A. Smith, D.G. Oscier, T.J. Hamblin, and M.J. Glennie The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis Blood 100 2002 3068 3076
21. Y. Yamada, N. Itano, H. Narimatsu, T. Kudo, S. Hirohashi, A. Ochiai, I. Tohnai, M. Ueda, and K. Kimata CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase- polymerase chain reaction Oncol. Rep. 10 2003 1919 1924
22. S. Pucci, E. Bonanno, F. Pichiorri, C. Angeloni, and L.G. Spagnoli Modulation of different clusterin isoforms in human colon tumorigenesis Oncogene 23 2004 2298 2304
23. G.I. Evan, G.K. Lewis, G. Ramsay, and J.M. Bishop Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product Mol. Cell. Biol. 5 1985 3610 3616
24. I. Stamenkovic, and B. Seed CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epsteinâ€"Barr virus-related cytoplasmic tail J. Exp. Med. 168 1988 1205 1210
25. S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D.J. Lipman Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res. 25 1997 3389 3402
26. A. Spurkland, J.E. Brinchmann, G. Markussen, F. Pedeutour, E. Munthe, T. Lea, F. Vartdal, and H.C. Aasheim Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites J. Biol. Chem. 273 1998 4539 4546
27. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanateâ€"phenolâ€"chloroform extraction Anal. Biochem. 162 1987 156 159
28. H.C. Aasheim, T. Logtenberg, and F. Larsen Subtractive hybridization for the isolation of differentially expressed genes using magnetic beads Methods Mol. Biol. 69 1997 115 128
29. J. Odeberg, T. Wood, A. Blucher, J. Rafter, G. Norstedt, and J. Lundeberg A cDNA RDA protocol using solid-phase technology suited for analysis in small tissue samples Biomol. Eng. 17 2000 1 9
30. R. Breathnach, and P. Chambon Organization and expression of eucaryotic split genes coding for proteins Annu. Rev. Biochem. 50 1981 349 383
31. P. Horton, and K. Nakai Better prediction of protein cellular localization sites with the k nearest neighbors classifier Proc. Int. Conf. Intell. Syst. Mol. Biol. 5 1997 147 152
32. M. Pagni, C. Iseli, T. Junier, L. Falquet, V. Jongeneel, and P. Bucher trEST, trGEN and hits: access to databases of predicted protein sequences Nucleic Acids Res. 29 2001 148 151
33. J. Dietrich, X. Hou, A.M. Wegener, L.O. Pedersen, N. Odum, and C. Geisler Molecular characterization of the di-leucine-based internalization motif of the T cell receptor J. Biol. Chem. 271 1996 11441 11448
34. J.D. Klemm, S.L. Schreiber, and G.R. Crabtree Dimerization as a regulatory mechanism in signal transduction Annu. Rev. Immunol. 16 1998 569 592
35. F.T. Yen, M. Masson, N. Clossais-Besnard, P. Andre, J.M. Grosset, L. Bougueleret, J.B. Dumas, O. Guerassimenko, and B.E. Bihain Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver J. Biol. Chem. 274 1999 13390 13398
36. D. Kaufmann, W. Leistner, P. Kruse, O. Kenner, S. Hoffmeyer, C. Hein, W. Vogel, L. Messiaen, and B. Bartelt Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2 Cancer Res. 62 2002 1503 1509
37. E. Ars, E. Serra, J. Garcia, H. Kruyer, A. Gaona, C. Lazaro, and X. Estivill Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1 Hum. Mol. Genet. 9 2000 237 247
38. M.R. Culbertson RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer Trends Genet. 15 1999 74 80